haloperidol
Generic: haloperidol
Labeler: advagen pharma ltdDrug Facts
Product Profile
Brand Name
haloperidol
Generic Name
haloperidol
Labeler
advagen pharma ltd
Dosage Form
SOLUTION, CONCENTRATE
Routes
Active Ingredients
haloperidol 2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
72888-173
Product ID
72888-173_45c7bbb4-7235-89a8-e063-6394a90a7ea0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA218371
Listing Expiration
2026-12-31
Marketing Start
2024-01-31
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
72888173
Hyphenated Format
72888-173
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
haloperidol (source: ndc)
Generic Name
haloperidol (source: ndc)
Application Number
ANDA218371 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/mL
Packaging
- 15 mL in 1 BOTTLE (72888-173-47)
- 120 mL in 1 BOTTLE (72888-173-48)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45c7bbb4-7235-89a8-e063-6394a90a7ea0", "openfda": {"nui": ["N0000180182"], "upc": ["0372888173474", "0372888173481"], "unii": ["J6292F8L3D"], "rxcui": ["141935"], "spl_set_id": ["8bfdc739-51b4-4914-9a60-923e83762307"], "pharm_class_epc": ["Typical Antipsychotic [EPC]"], "manufacturer_name": ["Advagen Pharma Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "15 mL in 1 BOTTLE (72888-173-47)", "package_ndc": "72888-173-47", "marketing_start_date": "20240131"}, {"sample": false, "description": "120 mL in 1 BOTTLE (72888-173-48)", "package_ndc": "72888-173-48", "marketing_start_date": "20240131"}], "brand_name": "Haloperidol", "product_id": "72888-173_45c7bbb4-7235-89a8-e063-6394a90a7ea0", "dosage_form": "SOLUTION, CONCENTRATE", "pharm_class": ["Typical Antipsychotic [EPC]"], "product_ndc": "72888-173", "generic_name": "Haloperidol", "labeler_name": "Advagen Pharma Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Haloperidol", "active_ingredients": [{"name": "HALOPERIDOL", "strength": "2 mg/mL"}], "application_number": "ANDA218371", "marketing_category": "ANDA", "marketing_start_date": "20240131", "listing_expiration_date": "20261231"}